Hydrocephalus is shifting from a device market to a multi-billion-dollar neurotechnology platform opportunity. In this episode, we explore the move from failure-prone shunts to adaptive, closed-loop systems integrating smart sensing, biologics, connectivity, and minimally invasive access. The companies that own the system architecture and data loop will define the next era of neurotech.